Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,958 total articles
Conexeu Sciences Inc., a Nasdaq-listed biotechnology company specializing in regenerative tissue therapies, announced five key leadership appointments including additions to its Board of Directors and the naming of a new Chief Commercial Officer. These leadership enhancements aim to strengthen the company's commercial and strategic capabilities as …
Cadrenal Therapeutics announced plans to initiate a Phase 2a proof-of-concept clinical trial for its drug candidate CAD-1005, targeting prevention of Acute Kidney Injury (AKI) associated with cardiac surgery (CSA-AKI). This expands the potential application of CAD-1005, which is already in late-stage development for heparin-induced thrombocytopenia…
QTREX Quantum Ltd. announced a major production milestone as one of the largest U.S.-based interconnect manufacturers adopted QTREX's Additively Manufactured Electronics (AME) technology for full production after extensive validation, achieving a 97% yield rate. This advancement marks QTREX's readiness for demanding manufacturing environments and s…
Aeries Technology has secured a strategic advisory engagement from a leading global tax and financial advisory firm to support the expansion of its India-based Global Capability Center (GCC) in a Tier-II city. This reflects a growing corporate trend of expanding GCCs beyond traditional metro areas to leverage deeper talent pools and improved operat…
Our Bond, Inc. announced a live investor webinar where CEO Doron Kempel will discuss new developments reinforcing the company's accelerating momentum in its AI-driven Preventative Personal Security platform. The company highlighted its global expansion, vast investment, and growing operational reach with trusted clients worldwide.
Polyrizon Ltd. announced a collaboration with a leading European medical center and a clinical research organization to conduct a human study evaluating the nasal residence time of its investigational NASARIX™ (PL-14) Allergy Blocker. This study aims to characterize the formulation's retention in the nasal cavity, aiding in quantifying the duration…
Fiserv, a global leader in payments and financial services technology, has announced Takis Georgakopoulos as its new CEO following Mike Lyons' departure to Truist Financial. Georgakopoulos brings extensive experience in payments, technology, AI, and cybersecurity. The company reaffirms its 2026 outlook with expected organic revenue growth of 1-3% a…
AIM ImmunoTech Inc., an immuno-pharma company focused on therapeutics for cancers, immune disorders, and viral diseases, announced it has regained compliance with NYSE American's continued listing standards by successfully addressing stockholders' equity deficiencies. The company raised approximately $8.5 million through warrant exercises and priva…
Smithfield Foods, through its Smithfield Culinary division, released survey results showing that meat quality and portion size are primary drivers of sandwich satisfaction and repeat customer visits. The survey of 2,000 U.S. consumers found strong preferences for hand-carved and deli-sliced meats and highlighted the opportunity for restaurants to e…
Neumora Therapeutics announced that its Phase 3 KOASTAL-2 and -3 trials of navacaprant for major depressive disorder failed to meet primary and key secondary endpoints. The company will cease development of navacaprant and realign its resources to advance other pipeline programs in Alzheimer's disease agitation, schizophrenia, and cardiometabolic d…
Advanced Flower Capital Inc. announced a quarterly dividend of $0.05 per share for the quarter ending June 30, 2026, payable on July 15, 2026. This dividend matches the payout from the prior quarter, reflecting steady dividend policy from the business development company which provides credit solutions to lower middle-market companies.
Sunrise Realty Trust, a Nasdaq-listed commercial real estate lender specializing in transitional projects in the Southern U.S., announced a quarterly dividend of $0.30 per share for Q2 2026, consistent with the previous quarter.
Oxford Lane Capital Corp. announced its unaudited net asset value (NAV) per share estimate for May 31, 2026, which is between $11.40 and $11.70. This preliminary estimate is subject to change and has not been approved by the board or undergone standard quarter-end procedures. The company highlighted potential impacts from market volatility on its p…
Tyson Foods, through its Hillshire Reserve brand, has launched a new premium lunchmeat line that emphasizes bold flavors, natural ingredients, and hardwood smoked meats. This new range aims to elevate everyday eating occasions with versatile and high-protein options, available now nationwide in select retailers. The product line complements changin…
Byrna Technologies Inc. announced a strategic realignment of its sales and marketing functions, splitting the combined role into two dedicated senior leadership positions to sharpen retail sales and brand positioning efforts. The company appointed HLK as its agency of record to lead brand strategy, creative development, and media outreach, aiming t…
OPKO Health's subsidiary OPKO Biologics presented preclinical data for its novel drug candidate OPK8801001 at ENDO 2026. The data demonstrated robust, dose-dependent suppression of IGF-1, indicating potential as a once-weekly treatment for acromegaly with stronger receptor antagonism than current therapies. This supports OPKO Biologics' capabilitie…
Grifols has launched FESILTY™, a new fibrinogen concentrate approved by the FDA in December for treatment of acute bleeding episodes in pediatric and adult patients with congenital fibrinogen deficiency (CFD). This product complements Grifols' bleeding management portfolio by providing a rapid, room-temperature stable, and precisely dosed treatment…
Swarmer, a US-based drone autonomy software company, announced a strategic partnership with Ukrainian firm Molfar Intelligence to integrate verified open-source intelligence data into Swarmer's AI models. This collaboration aims to improve autonomous decision-making and object recognition in contested environments by using real combat-verified data…
Chaince Digital Holdings Inc., listed on Nasdaq as CD, announced the launch of its USDC Yield Vault on the Morpho open decentralized lending protocol. In collaboration with AlphaPing GmbH, the vault offers depositors curated on-chain lending strategies targeting yield from structured credit, delta-neutral yield strategies, and tokenized fixed incom…
Rectitude Holdings Ltd has secured additional orders for its flagship SuperSun All-in-One Intelligence Micro-Grid (AIMS) systems across multiple major public housing, private residential, and healthcare infrastructure projects in Singapore. The company has won a multi-site blanket order and a dedicated project engagement with Tanglin Corporation, p…
Enlivex Ltd. announced the issuance of an Australian patent protecting the use of its immunotherapy Allocetra™ for treating osteoarthritis. This patent extends protection through at least 2040 and strengthens Enlivex's global intellectual property portfolio as it advances its Phase 2b clinical trials targeting moderate-to-severe age-related knee os…
Humacyte announced positive Phase 3 trial results for its bioengineered acellular tissue engineered vessel (ATEV), which outperformed the standard autologous arteriovenous (AV) fistula for women on dialysis by extending catheter-free days and reducing infection rates. The trial showed women with ATEV avoided catheter use on average 3 months longer …
Enphase Energy announced the appointment of Shanker Trivedi, former NVIDIA senior vice president of enterprise business, to its board of directors. Trivedi's expertise in AI, data centers, and enterprise infrastructure is expected to support Enphase's expansion in energy management, power conversion, and AI-driven energy infrastructure solutions. T…
Spyre Therapeutics announced that SPY002, its anti-TL1A investigational antibody for moderate-to-severe ulcerative colitis (UC), met its primary endpoint in the Phase 2 SKYLINE trial Part A. The therapy demonstrated a significant reduction in Robart's Histopathology Index score by 10.7 points at Week 12, with notable clinical remission and endoscop…
VisionWave Holdings, a Nasdaq-listed technology company, announced filing a U.S. provisional patent and trademark application for SDNN™, a Symbiotic Deep Neural Network architecture designed to enable real-time multi-source sensor fusion, adaptive reasoning, and coordinated control across defense, security, robotics, and civil infrastructure applic…
